Effect of risk-reducing salpingo-oophorectomy on sex steroid hormone serum levels among postmenopausal women: an NRG Oncology/Gynecologic Oncology Group study
L. Phuong, Mark E. Sherman(Mayo Clinic in Florida), Susan C. Modesitt(University of Virginia Health System), Thomas Amatruda(Metro-Minnesota Community Oncology Research Consortium), John F. Boggess(University of Kentucky), Kristin Bixel(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Gretchen Glaser(WinnMed), Roni T. Falk(National Cancer Institute), Amanda Black(St. Elizabeth's Hospital), Mark H. Greene(Cancer Institute (WIA)), Katherine Tucker(Prince of Wales Hospital), Austin Miller(Roswell Park Comprehensive Cancer Center), Kelly J. Wilkinson(University of Mississippi Medical Center), Ashley Stuckey(Providence College), Cheung Wong(University of Vermont Medical Center), Peter G. Rose(Cleveland Clinic), S. Diane Yamada(University of Chicago), Gustavo C. Rodriguez(NorthShore University HealthSystem)
Cited by 5
Related Papers
Integrated genomic analyses of ovarian carcinoma
|Nature|2011|8.2k
Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective
|JNCI Journal of the National Cancer Institute|1995|3.4k
A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study
|The Lancet Oncology|2017|929
Tumor-infiltrating NY-ESO-1–specific CD8 <sup>+</sup> T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer
|Proceedings of the National Academy of Sciences|2010|844
Tumor necrosis factor antagonist therapy and lymphoma development: Twenty‐six cases reported to the Food and Drug Administration
|Arthritis & Rheumatism|2002|661